Skip to content

Laura T. Lawrence, M.D.

NPI 1346284627ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Dallas, TX

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in Dallas, Texas, licensed in TX and MO, with an NPI issued in June 2006. Ferring Pharmaceuticals Inc. was the largest of 4 companies reporting payments in 2025, $347.25 in all, mostly food and beverage.

Overview

NPI1346284627
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJun 16, 2006
Last updated in NPPESFeb 24, 2016

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$347.25 · 27 payments from 4 companies
  • 2024$457.04 · 34 payments from 6 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$161.8316
Organon LLC$142.078
Meditrina$25.582
Emd Serono, Inc.$17.771

What the 2025 payments were for

  • Food and Beverage$347.25 · 27 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Dallas

All 28 Obstetrics & Gynecology, Reproductive Endocrinology providers in Dallas · All Obstetrics & Gynecology, Reproductive Endocrinology providers in Texas